Physician profile
Eric J Snowden
NPI 1548767114
$4,252.38
in general payments reported to CMS, 2019-2025
18 companies · $248 in 2025
The $248 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2020: $39.71 · 2021: $16.20 · 2022: $5.88 · 2023: $40.09 · 2024: $3,660 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $947.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $947.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,189.91 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $240.83 | 2020-2025 | Fasenra, Breztri, Tezspire |
| Glaxosmithkline, LLC. | $155.70 | 2019-2024 | Trelegy Ellipta, Nucala |
| E.R. Squibb & Sons, L.L.C. | $122.14 | 2019 | |
| Grifols USA, LLC | $97.39 | 2024 | Prolastin-C Liquid |
| Regeneron Healthcare Solutions, INC. | $67.10 | 2024 | Dupixent |
| Insmed, INC. | $59.99 | 2025 | Arikayce, Brinsupri |
| Abbvie INC. | $51.38 | 2024-2025 | |
| Mallinckrodt Hospital Products INC. | $48.15 | 2020-2025 | Acthar |
| Amgen INC. | $47.35 | 2024 | Tezspire |
| Edwards Lifesciences Corporation | $40.09 | 2023 | Hemosphere |
| Viatris Specialty LLC | $33.31 | 2025 | Yupelri |
| Genzyme Corporation | $23.38 | 2024 | |
| Merck Sharp & Dohme LLC | $21.99 | 2025 | Zerbaxa |
| Actelion Pharmaceuticals US, INC. | $17.94 | 2025 | Opsynvi, Uptravi |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $15.61 | 2025 | Ohtuvayre |
| Galvanize Therapeutics, INC | $14.24 | 2025 | Aliya System |
| Ambu INC. | $5.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Snowden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.